rs202141372
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_017780.4(CHD7):c.2835+8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,613,294 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017780.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHD7 | NM_017780.4 | c.2835+8T>C | splice_region_variant, intron_variant | ENST00000423902.7 | NP_060250.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD7 | ENST00000423902.7 | c.2835+8T>C | splice_region_variant, intron_variant | 5 | NM_017780.4 | ENSP00000392028 | P1 | |||
CHD7 | ENST00000524602.5 | c.1717-40294T>C | intron_variant | 1 | ENSP00000437061 | |||||
CHD7 | ENST00000525508.1 | c.2835+8T>C | splice_region_variant, intron_variant | 5 | ENSP00000436027 | |||||
CHD7 | ENST00000695853.1 | c.2835+8T>C | splice_region_variant, intron_variant, NMD_transcript_variant | ENSP00000512218 |
Frequencies
GnomAD3 genomes AF: 0.000625 AC: 95AN: 152012Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000564 AC: 140AN: 248104Hom.: 0 AF XY: 0.000609 AC XY: 82AN XY: 134592
GnomAD4 exome AF: 0.00106 AC: 1554AN: 1461164Hom.: 1 Cov.: 32 AF XY: 0.000995 AC XY: 723AN XY: 726822
GnomAD4 genome AF: 0.000624 AC: 95AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 20, 2014 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 29, 2015 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 04, 2016 | Variant summary: The variant of interest is located at a non-conserved intronic position, not widely known to affect splicing with 5/5 in silico programs via Alamut predicting no significant effect on splicing, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 69/108302 (1/1569), predominantly in the European (Non-Finnish) cohort, 55/60222 (1/1094), which exceeds the maximum expected allele frequency for a pathogenic CHD7 variant of 1/769230. The variant of interest has been reported in one individual affected with normosmic idiopathic hypogonadotropic hypogonadism via publications. Multiple reputable clinical laboratories have cited the variant with varying classifications: "uncertain significance" or "likely benign." Therefore, taking all available lines of evidence into consideration, the variant of interest is classified as Benign. - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | CHD7: BP4, BS1 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 25, 2019 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 24, 2014 | The c.2835+8T>C intronic variant results from a T to C substitution 8 nucleotides after coding exon 9 in the CHD7 gene. This variant was previously reported in the SNPDatabase as rs202141372. Based on data from the 1000 Genomes Project, the C allele has an overall frequency of approximately 0.05% (1/2098) total alleles studied. The highest observed frequency was 0.59% (1/170) CEPH alleles. Based on data from the NHLBI Exome Sequencing Project (ESP), the C allele has an overall frequency of approximately 0.09% (11/12068) total alleles studied, having been observed in 0.03% (1/3804) African American alleles and 0.12% (10/8264) European American alleles. This nucleotide position is poorly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on this donor splice site; however, direct evidence is unavailable. - |
CHARGE syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Hypogonadotropic hypogonadism 5 with or without anosmia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 13, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at